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Additive manufacturing (AM) has been labelled a 
disruptive technology for its ability to produce customised 
geometrically complex objects in small quantities at low 
cost.[1] The Economist has called it the third industrial 
revolution. Unlike traditional manufacturing, which is 
subtractive in that large volumes of material are reduced to desired shapes 
by removing excess, AM constructs 3D objects by adding materials layer 
by layer under computer control based on 3D models. 
AM creates complex shapes yet makes efficient use of raw materials, 
producing minimal waste and requiring minimal tools. [2] The 
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geometric flexibility of the process, mostly attributable to its additive 
nature, has led to various non-industrial applications, notably those in 
medicine. Some medical applications of AM include construction of 
anatomical models for surgery planning, and design and construction 
of customised prosthetic implants. The raw materials used in AM 
for these applications include plastics, resins, alloys, stainless steel, 
titanium, polymers and ceramics.[1] Layers of material can be built and 
consolidated in a variety of ways. 3D printing is a fast form of AM and 
is available in low-cost, low-resolution format. It places production 
capability in the hands of the designer, facilitated by the availability of 
computing technology that translates 3D designs into printable files. 
3D printers operate similarly to traditional laser or inkjet printers, but 
with the ink replaced by the materials from which the objects are to 
be built. They deposit material layer by layer and bind it chemically 
using a binder sprayed through a nozzle; further strengthening may 
be achieved with the application of heat. The unbound material is 
removed chemically. The printer interfaces with computer-aided 
design (CAD) software to specify the shape of the object. 
Patient-specific physical models of anatomical structures serve as an 
aid for surgical planning to highlight areas of interest and for surgery 
rehearsal to determine possible complications and reduce operating 
time.[3] Such models are produced using AM after CAD translation of 
volumetric images from 3D modalities such as computed tomography 
and magnetic resonance imaging. Although 3D visualisation using 
specialised viewers is available for surgical planning,[4] 3D images 
are typically viewed on 2D screens. This limitation can be overcome 
using physical 3D models. The ability of images to differentiate soft-
tissue types remains a constraint, and models of hard tissue are more 
commonly reported than those of soft tissue.[5] Physical models have 
been used successfully in cranio- and maxillofacial, pelvic, neuro-, 
spine, cardiovascular and visceral surgery.[3]
Among its potential medical applications, the use of AM in the 
production of implants, particularly to replace bony structures, is 
perhaps the best known. AM techniques allow the design of patient-
specific prosthetic implants to suit individual anatomy for improved 
fit, functionality and aesthetics, and to reduce the likelihood of implant 
failure. Examples include customised mandibles, hips, knees and cranial 
plates. AM is commonly used in dentistry, and a variety of dental 
products, such as bridges and crowns, are commercially available.[2] AM 
has also influenced the production of hearing aids, devices that require a 
high degree of customisation for individual fit. Greater ease of regulatory 
approval for devices worn on the body than for implants has assisted 
widespread adoption of AM-produced hearing aids, with the result that 
AM accounts for 99% of those that are placed in the ear.[6] 
In addition to the implantation of fabricated prostheses, surgical 
techniques adopted to repair defects and replace bone and other tissue 
that the body is unable to produce include autologous bone grafts (the 
gold standard – originating from another site in the same patient), 
allografts (from human donors) or xenografts (from animals). Autografts 
are associated with long recovery periods, donor site morbidity and 
a complex graft-shaping process to achieve biomechanical coupling; 
allografts and xenografts carry the possibility of immuno-rejection, 
inflammation and disease transmission, as well as poor mechanical 
performance.[7] For these reasons, tissue regeneration or engineering 
approaches are being explored. AM has been used as a tool in tissue 
regeneration through the production of biocompatible or biodegradable 
scaffolds – structures that serve as a platform to guide the growth of new 
tissues to replace damaged or defective ones.[5] Scaffolds act not only 
as passive matrices to support cell adhesion or proliferation, but also 
as vehicles for the delivery of bioactive molecules, nutrients and waste 
products.[7] Their functional specifications translate into fabrication 
requirements for spatially varying structures with high geometric 
complexity coupled with different biomaterials. Such ‘biofabrication’ can 
be accommodated by AM techniques in combination with CAD and 
medical imaging.[8] While tissue engineering is still in its technological 
infancy, scaffolds have been clinically successful in building bladder and 
bronchus,[9] bone, osteochondral tissue, cartilage and skin. Techniques to 
develop new vasculature are being explored.[8]
Scaffolding is the traditional tissue engineering approach but has limited 
ability for cell manipulation and control of cell placement. Incorporating 
viable cells into biofabricated structures remains a challenge.[8] Organ 
printing through controlled deposition of cells or cell aggregates is an 
alternative to scaffolds, offering more precise cellular positioning.[10] 
Manufactured organs are, however, an elusive goal. Patches of organ 
tissue – including liver, kidney and heart – that have been printed to date 
have generally not exceeded a few millimetres in area and a few layers in 
cell depth. Thicker structures would require a vascular system to supply 
nutrients and oxygen; the requirement for an embedded vasculature and 
limits to the current understanding of interactions between cells and 
their environment are challenges to the production of viable organs.[11] 
Nonetheless, the ultimate possibility of organ printing in vivo, with the aid 
of a biofabrication device as a surgical tool, has been suggested.[12]
More immediate applications of tissue engineering transcend its 
traditional purpose of generating tissues for repair or restoration and 
lie in the discovery, development and testing of drugs. Biofabrication 
can produce models of both health and disease. Fabricated tissues 
can provide a more realistic platform for preclinical testing of 
pharmaceuticals than the cultured cells and animal models that are 
currently used. Tissue models can be designed to answer very specific 
research questions and used as test platforms for new treatments and 
vaccines.[13] Personalised therapy is another potential application, e.g. 
printed models of tumours can be subjected to therapies in vitro and 
their responses used to design patient-specific cancer treatment.[11] 
Engineered tissue models can also be valuable research tools. They have 
the potential to provide the heterogeneity of mechanics and structure that 
are lacking in the cellular aggregates currently used in biological studies 
of disease. They can be used to examine complex cellular pathways and 
behaviours in a variety of biological conditions to aid the understanding of 
disease progression and the design of approaches for prevention.[13] 
The ability of AM technology to deliver customised products to suit 
individual needs holds great promise for personalised healthcare. There 
have been some clinical successes with AM-based surgical planning, 
implants, assistive devices and scaffold-based tissue engineering. 
Biofabrication of tissues and organs that mimic in vivo structure and 
function remains fraught with challenges, but offers exciting prospects 
and may contribute in significant ways to the ‘century of biology’.
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